Navigation Links
UT Southwestern patient first in North Texas to receive newest-generation heart failure device
Date:10/26/2009

DALLAS Oct. 27, 2009 UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant.

Called a left-ventricular assist device (LVAD), its purpose is to help a patient's weakened heart pump blood throughout the body. For Mr. LeBlanc, it will help his ailing heart continue to pump until the Irving resident receives a new heart. UT Southwestern is the only medical facility in North Texas implanting the HeartWare Ventricular Assist System as part of a national clinical trial testing the effectiveness of the device.

The HeartWare Ventricular Assist System is a little smaller than a hockey puck and two and half times smaller than the earliest versions of LVADs.

Mr. LeBlanc, a Chicago native, moved to the Dallas area 11 years ago in search of new job opportunities. The normal trajectory of his daily life veered wildly when a simple episode of fainting resulted in a life-changing diagnosis: heart failure.

"I kept getting weaker and weaker," he said. "I was blacking out for no reason. I hadn't been sick and have never been a sickly person."

Occasionally, viruses can attack the heart and leave it severely damaged, but people may not know until months or years later. Mr. LeBlanc's doctors theorized he may have had such a virus that ultimately led to heart failure.

"My energy level was up and down. To keep me going, I qualified for a defibrillator, which basically shocked me if my heart rhythm started to get worse," Mr. LeBlanc said. "But as I got sicker, the defibrillator kept going off, and it was awful."

Even with the defibrillator, Mr. LeBlanc suffered a heart attack in April, followed by a stroke in July. Luckily, he was able to get to an emergency room before the stroke did too much damage. After several more weeks in and out of
'/>"/>

Contact: Katherine Morales
katherine.morales@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Ice cream may target the brain before your hips, UT Southwestern study suggests
2. UT Southwestern researchers examine mechanisms that help cancer cells proliferate
3. UT Southwestern researchers probe kidney damage, protection in lupus
4. Diabetics on high-fiber diets might need extra calcium, report UT Southwestern researchers
5. Two UT Southwestern researchers awarded Sloan fellowships
6. UT Southwestern researchers identify molecule that helps the sleep-deprived to mentally rebound
7. UT Southwestern researchers disrupt biochemical system involved in cancer, degenerative disease
8. Natural brain substance blocks weight gain in mice, UT Southwestern researchers discover
9. UT Southwestern scientist honored among best in Texas research
10. UT Southwestern researchers identify gene linked to inherited form of fatal lung disease
11. Deranged calcium signaling contributes to neurological disorder, UT Southwestern researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... MARC (Maximizing Access to Research Careers) Program has announced ... Human Genetics from October 18 22, 2014 in ... promote the entry of students, post doctorates and scientists ... science community and to encourage the participation of young ... This year MARC conferred 16 awards totaling $29,600., The ...
(Date:8/28/2014)... identified the developmental on-off switch for Streptomyces , ... two-thirds of the world,s naturally derived antibiotic medicines. ... it is possible to manipulate this switch to make ... appearing August 28 in Cell , found that ... and a larger protein called BldD ultimately controls whether ...
(Date:8/28/2014)... measuring and imaging how quickly blood flows in the ... drug abuse affects the brain, which may aid in ... better treatment options for recovering drug addicts. The new ... Brook University in New York, USA and the U.S. ... Optical Society,s (OSA) open-access journal Biomedical Optics ...
Breaking Biology News(10 mins):Small molecule acts as on-off switch for nature's antibiotic factory 2Small molecule acts as on-off switch for nature's antibiotic factory 3This is your brain's blood vessels on drugs 2This is your brain's blood vessels on drugs 3
... even a small amount of MDMA, better known as ecstasy, ... study to look at the neurotoxic effects of low doses ... were presented today at the annual meeting of the Radiological ... in blood circulation in some areas of the brain in ...
... India constitute more than one-sixth of the world's ... related to genetic diseases. And with the growth ... and western lifestyles have risen to near-epidemic proportions, ... importance. , In response to this dearth ...
... has yielded new evidence for domesticated horses up to 5,600 ... appear to be the remains of horse corrals beside pit ... by horse manure. The Krasnyi Yar site was inhabited by ... relied heavily on horses for food, tools, and transport. , ...
Cached Biology News:Ecstasy can harm the brains of first-time users 2Researchers make progress in studying genetic traits of India-born populations 2New evidence of early horse domestication 2New evidence of early horse domestication 3
(Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... be valued at $5.6 billion in 2019. It ... 18.1% from 2013 to 2019, and was valued ... research report published by Transparency Market Research. , ... please visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research ...
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 Pittcon ... Hub MacDonald, and colleague Koichiro Matsuda, Horiba Scientific, have ... on September 5, 2014. JASIS , Asia’s largest ... 3-5, 2014, in Makuhari Messe, Japan. , The ... Tools for Bioanalysis from Single Molecules to Single Cells” ...
(Date:8/29/2014)... Local veterinarian, Dr. Keith Clement, and his ... to participate in an investigational study of donor stem ... of this study is to determine if a single ... arthritically affected joints can help reduce pain and inflammation ... current investigational study must be older than nine months, ...
(Date:8/29/2014)... 29, 2014 Due to a misstatement posted ... the Adult Stem Cell Technology Center, LLC ( ASCTC ) ... cell therapy research that might benefit ALS patients. Because ... new stem cell technologies and therapeutic applications, FRC listed ASCTC ... Challenge donors who wish not to support research that ...
Breaking Biology Technology:Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2Burnt Hills Veterinary Hospital Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... SAN FRANCISCO, Jan. 10, 2011 Enobia Pharma Inc., ... II study of ENB-0040, a bone targeted enzyme replacement ... serious, rare metabolic bone disorder. The results were presented ... of Enobia, at the 29th Annual J.P. Morgan Healthcare ...
... (Nasdaq: PRXL ) will release Second Quarter Fiscal ... the close of the stock market.  The announcement will be ... the PR Newswire website at www.prnewswire.com . ... 10:00 a.m. EST on Tuesday, February 1, 2011 to discuss ...
... DuPont (NYSE: DD ) has entered ... a global enzyme and specialty food ingredients company, for ... of Danisco net debt.  Upon closing, this transaction would ... with science-intensive innovations that address global challenges in food ...
Cached Biology Technology:Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 2Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy 3PAREXEL Announces Date of Second Quarter Fiscal Year 2011 Earnings Release and Conference Call 2DuPont to Acquire Danisco for $6.3 Billion 2DuPont to Acquire Danisco for $6.3 Billion 3DuPont to Acquire Danisco for $6.3 Billion 4
... conserved form of cell suicide, which follows ... component of this process is a cascade ... enzymes participate in a series of reactions ... signals and result in the cleavage of ...
... System provides optimized reagents and protocols for ... genes by insertion of group II introns. ... group II introns and utilizes a simple ... II intron for specific insertion into the ...
Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...
Mouse monoclonal antibody raised against a partial recombinant QARS. NCBI Entrez Gene ID = QARS...
Biology Products: